These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 20958028

  • 1. Local cooperativity in an amyloidogenic state of human lysozyme observed at atomic resolution.
    Dhulesia A, Cremades N, Kumita JR, Hsu ST, Mossuto MF, Dumoulin M, Nietlispach D, Akke M, Salvatella X, Dobson CM.
    J Am Chem Soc; 2010 Nov 10; 132(44):15580-8. PubMed ID: 20958028
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Characterization of the structure and dynamics of amyloidogenic variants of human lysozyme by NMR spectroscopy.
    Chamberlain AK, Receveur V, Spencer A, Redfield C, Dobson CM.
    Protein Sci; 2001 Dec 10; 10(12):2525-30. PubMed ID: 11714920
    [Abstract] [Full Text] [Related]

  • 5. In silico prediction of novel residues involved in amyloid primary nucleation of human I56T and D67H lysozyme.
    Griffin JWD, Bradshaw PC.
    BMC Struct Biol; 2018 Jul 20; 18(1):9. PubMed ID: 30029603
    [Abstract] [Full Text] [Related]

  • 6. Mechanistic studies of the folding of human lysozyme and the origin of amyloidogenic behavior in its disease-related variants.
    Canet D, Sunde M, Last AM, Miranker A, Spencer A, Robinson CV, Dobson CM.
    Biochemistry; 1999 May 18; 38(20):6419-27. PubMed ID: 10350460
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis.
    Booth DR, Sunde M, Bellotti V, Robinson CV, Hutchinson WL, Fraser PE, Hawkins PN, Dobson CM, Radford SE, Blake CC, Pepys MB.
    Nature; 1997 Feb 27; 385(6619):787-93. PubMed ID: 9039909
    [Abstract] [Full Text] [Related]

  • 9. Engineering a camelid antibody fragment that binds to the active site of human lysozyme and inhibits its conversion into amyloid fibrils.
    Chan PH, Pardon E, Menzer L, De Genst E, Kumita JR, Christodoulou J, Saerens D, Brans A, Bouillenne F, Archer DB, Robinson CV, Muyldermans S, Matagne A, Redfield C, Wyns L, Dobson CM, Dumoulin M.
    Biochemistry; 2008 Oct 21; 47(42):11041-54. PubMed ID: 18816062
    [Abstract] [Full Text] [Related]

  • 10. Identification of the core structure of lysozyme amyloid fibrils by proteolysis.
    Frare E, Mossuto MF, Polverino de Laureto P, Dumoulin M, Dobson CM, Fontana A.
    J Mol Biol; 2006 Aug 18; 361(3):551-61. PubMed ID: 16859705
    [Abstract] [Full Text] [Related]

  • 11. Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations.
    Dumoulin M, Canet D, Last AM, Pardon E, Archer DB, Muyldermans S, Wyns L, Matagne A, Robinson CV, Redfield C, Dobson CM.
    J Mol Biol; 2005 Feb 25; 346(3):773-88. PubMed ID: 15713462
    [Abstract] [Full Text] [Related]

  • 12. A comparative study of fibrillation kinetics of two homologous proteins under identical solution condition.
    Chaudhary AP, Vispute NH, Shukla VK, Ahmad B.
    Biochimie; 2017 Jan 25; 132():75-84. PubMed ID: 27825804
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Local cooperativity in the unfolding of an amyloidogenic variant of human lysozyme.
    Canet D, Last AM, Tito P, Sunde M, Spencer A, Archer DB, Redfield C, Robinson CV, Dobson CM.
    Nat Struct Biol; 2002 Apr 25; 9(4):308-15. PubMed ID: 11887182
    [Abstract] [Full Text] [Related]

  • 17. A highly amyloidogenic region of hen lysozyme.
    Frare E, Polverino De Laureto P, Zurdo J, Dobson CM, Fontana A.
    J Mol Biol; 2004 Jul 23; 340(5):1153-65. PubMed ID: 15236974
    [Abstract] [Full Text] [Related]

  • 18. Structural and folding dynamic properties of the T70N variant of human lysozyme.
    Esposito G, Garcia J, Mangione P, Giorgetti S, Corazza A, Viglino P, Chiti F, Andreola A, Dumy P, Booth D, Hawkins PN, Bellotti V.
    J Biol Chem; 2003 Jul 11; 278(28):25910-8. PubMed ID: 12709420
    [Abstract] [Full Text] [Related]

  • 19. Characterisation of the structural, dynamic and aggregation properties of the W64R amyloidogenic variant of human lysozyme.
    Vettore N, Moray J, Brans A, Herman R, Charlier P, Kumita JR, Kerff F, Dobson CM, Dumoulin M.
    Biophys Chem; 2021 Apr 11; 271():106563. PubMed ID: 33640796
    [Abstract] [Full Text] [Related]

  • 20. Rationalising lysozyme amyloidosis: insights from the structure and solution dynamics of T70N lysozyme.
    Johnson RJ, Christodoulou J, Dumoulin M, Caddy GL, Alcocer MJ, Murtagh GJ, Kumita JR, Larsson G, Robinson CV, Archer DB, Luisi B, Dobson CM.
    J Mol Biol; 2005 Sep 30; 352(4):823-36. PubMed ID: 16126226
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.